Long-acting inhaled bronchodilators for cystic fibrosis

This review aims to evaluate long-acting inhaled bronchodilators in children and adults with CF in terms of improving clinical outcomes and safety. If possible, we aim to assess the optimal drug and dosage regimen.

This is a protocol.

Share/Save